Brazilian court clears GSK/Pfizer divestiture

A federal judge in Brazil has reportedly approved Pfizer's sale of assets to Aspen Pharmacare, ending a suspension caused by lack of quorum at the country’s competition watchdog.

Get unlimited access to all Global Competition Review content